After bungling containment, the Trump administration hopes for a fast-tracked fix. But compressing trials comes with its own hazards.

As the coronavirus that causes Covid-19 sweeps across the world, scientists are racing to find vaccines that could stop the virus in its tracks.

On Monday, Moderna Therapeutics, a Massachusetts-based company, began the first human clinical trials of its vaccine in Seattle, Washington—skipping the typical phase of trials wherein a new vaccine or medication is tested on animals first.

A successful vaccine could be a lifesaver for many. But bioethicists are also concerned about the compressed timeline—and what it means for vaccine development in the future. Read more at The New Republic.